ForDoz receives USFDA approval for Doxorubicin Hydrochloride Liposome injection
Indicated for treatment of ovarian cancer, acquired immune deficiency syndrome (AIDS)-related Kaposi’s Sarcoma, and multiple…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lupin
Lupin and Huons sign license and supply agreement for commercialisation of Cyclosporine Ophthalmic…
Lupin expands ophthalmic care reach with treatment for dry eye syndrome and corneal ulcers in the Mexican market
Lupin receives tentative approval from U.S. FDA for Sodium Sulfate, Magnesium Sulfate, and Potassium…
The drug will be manufactured at Lupin’s Nagpur facility, India
Lupin receives approval from U.S. FDA for Topiramate Extended-Release Capsules
The company to market a generic equivalent of Trokendi XR Extended-Release Capsules
Lupin receives EIR from U.S. FDA for its Dabhasa facility
The facility receives U.S. FDA 'No Action Indicated' status
Lupin gains tentative FDA approval for Empagliflozin, Linagliptin, Metformin Hydrochloride ER…
This product will be manufactured at Lupin’s Pithampur facility in India
Lupin receives tentative approval for Olopatadine Hydrochloride Ophthalmic Solution
The drug is a generic equivalent of Pataday Once Daily Relief, 0.7 per cent (OTC)
Lupin gains EIR from US FDA for its Somerset manufacturing facility
The facility was inspected from May 7 to May 17, 2024
Lupin appoints Abdelaziz Toumi as CEO of its API CDMO subsidiary
Holding a Doctorate in chemical engineering, Abdel, brings over two decades of experience in the biotech, pharma and CDMO sectors…
Lupin announces closure of US FDA inspection
The inspection was conducted at its injectables facility in Nagpur